Single Dose Study of Controlled-Release Paroxetine Tablets in Healthy Japanese Male Subjects

NCT00938184 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder

Interventions

DRUG: Paroxetine 12.5 milligrams tablet
DRUG: Paroxetine 25 milligrams tablet
DRUG: Paroxetine 50 milligrams tablet

Sponsor

GlaxoSmithKline